Literature DB >> 21338447

Oral administration of Lactobacillus strains from Kimchi inhibits atopic dermatitis in NC / Nga mice.

T J Won1, B Kim, Y T Lim, D S Song, S-Y Park, E S Park, D I Lee, K W Hwang.   

Abstract

AIMS: Atopic dermatitis (AD) is marked by elevated levels of immunoglobulin E and skin lesions such as oedema and haemorrhage. Kimchi is a Korean fermented food that contains beneficial bacteria for human health. In this study, Lactobacillus plantarum CJLP55, CJLP56, CJLP133 and CJLP136 isolated from Kimchi were investigated for their capacity to inhibit AD. METHODS AND
RESULTS: The three strains, CJLP55, CJLP133 and CJLP136, suppressed AD-like skin lesions, high serum IgE levels and epidermal thickening. The three strains diminished the accumulation of eosinophils and mast cells into topical inflammatory sites and the enlargement of axillary lymph nodes, which are responsible for the dorsal dermatitis. CJLP55, CJLP133 and CJLP136 decreased production of type 2 cytokines such as IL-4 and IL-5 in lymph node cell culture. CJLP133 and CJLP136 increased IFN-γ secretion, while CJLP55 enhanced IL-10 production.
CONCLUSIONS: The three strains isolated from Kimchi suppress house-dust mite-induced dermatitis in NC/Nga mouse, a representative animal model of human AD. SIGNIFICANCE AND IMPACT OF THE STUDY: These findings suggest that lactobacilli isolated from Kimchi inhibit AD, probably by altering the balance of Th1/Th2 ratio or inducing IL-10 production.
© 2011 The Authors. Journal of Applied Microbiology © 2011 The Society for Applied Microbiology.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21338447     DOI: 10.1111/j.1365-2672.2011.04981.x

Source DB:  PubMed          Journal:  J Appl Microbiol        ISSN: 1364-5072            Impact factor:   3.772


  21 in total

1.  What Does the Taste System Tell Us About the Nutritional Composition and Toxicity of Foods?

Authors:  John I Glendinning
Journal:  Handb Exp Pharmacol       Date:  2022

Review 2.  An evolutionary perspective on food and human taste.

Authors:  Paul A S Breslin
Journal:  Curr Biol       Date:  2013-05-06       Impact factor: 10.834

Review 3.  Fermented dairy products as delivery vehicles of novel probiotic strains isolated from traditional fermented Asian foods.

Authors:  Kariyawasam Majuwana Gamage Menaka Menike Kariyawasam; Na-Kyoung Lee; Hyun-Dong Paik
Journal:  J Food Sci Technol       Date:  2020-10-23       Impact factor: 3.117

Review 4.  Preventative and therapeutic probiotic use in allergic skin conditions: experimental and clinical findings.

Authors:  Öner Özdemir; Azize Yasemin Göksu Erol
Journal:  Biomed Res Int       Date:  2013-09-01       Impact factor: 3.411

5.  Development of Gut Microbiota in a Mouse Model of Ovalbumin-induced Allergic Diarrhea under Sub-barrier System.

Authors:  Juan-Hong Wang; Song-Wei Fan; Wei-Yun Zhu
Journal:  Asian-Australas J Anim Sci       Date:  2013-04       Impact factor: 2.509

6.  Efficacy of Probiotic Therapy on Atopic Dermatitis in Children: A Randomized, Double-blind, Placebo-controlled Trial.

Authors:  Hyeon-Jong Yang; Taek Ki Min; Hae Won Lee; Bok Yang Pyun
Journal:  Allergy Asthma Immunol Res       Date:  2013-12-12       Impact factor: 5.764

7.  Immunomodulatory Activity of Lactococcus lactis A17 from Taiwan Fermented Cabbage in OVA-Sensitized BALB/c Mice.

Authors:  Hui-Ching Mei; Yen-Wenn Liu; Yi-Chin Chiang; Shiou-Huei Chao; Nai-Wen Mei; Yu-Wen Liu; Ying-Chieh Tsai
Journal:  Evid Based Complement Alternat Med       Date:  2013-01-21       Impact factor: 2.629

8.  Immune disorders and its correlation with gut microbiome.

Authors:  Ji-Sun Hwang; Chang-Rok Im; Sin-Hyeog Im
Journal:  Immune Netw       Date:  2012-08-31       Impact factor: 6.303

Review 9.  Clinical efficacy and mechanism of probiotics in allergic diseases.

Authors:  Ha-Jung Kim; Hyung Young Kim; So-Yeon Lee; Ju-Hee Seo; Eun Lee; Soo-Jong Hong
Journal:  Korean J Pediatr       Date:  2013-09-30

10.  Oral administration of heat-inactivated Lactobacillus plantarum K37 modulated airway hyperresponsiveness in ovalbumin-sensitized BALB/c mice.

Authors:  Yen-Wenn Liu; Tan-Wei Liao; Yu-Han Chen; Yi-Chin Chiang; Ying-Chieh Tsai
Journal:  PLoS One       Date:  2014-06-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.